In our tumor model, we observed that anti-PD-1 treatment induced a subtle increase in the percentages of terminally exhausted CD101+ TIM3+ cells in both WT and Suv39h1KO CD8+ TILs. The gene discussed is CD101; the disease is neoplasm.